TG Therapeutics, Inc. (NASDAQ: TGTX) reported Q1 EPS of ($0.25), $0.06 worse than the analyst estimate of ($0.19).TG Therapeutics, Inc. reaffirmed FY2014 guidance.

For earnings history and earnings-related data on TG Therapeutics, Inc. (TGTX) click here.